欧美巨大另类极品video-欧美巨大性爽-欧美巨乳勺A片-欧美巨乳亚洲第一社区-欧美亅性猛交内射-欧美军人男同志做受69

NKF's subsidiary Kindos’s self-developed Ropivacaine Hydrochloride Injection gets FDA approval for marketing

This once again fully demonstrates Kindos team the professional and efficient R&D capability, the international first-class cGMP manufacturing capability and the precise and rigorous pharmaceutical registration capability.

2024-08-07

Learn more +
Meitheal Pharmaceuticals Strengthens Biologics Portfolio with an Exclusive Commercial Licensing Agreement for YUSIMRY®, a Biosimilar of Humira®

Meitheal will work closely with Coherus to ensure a seamless transition of existing YUSIMRY® operations.

2024-06-27

Learn more +
Eptifibatide injection approved by USFDA，from Nanjing King-Friend subsidiary

May 9, 2024, Hong Kong King-Friend Industrial Company Limited. (hereinafter referred to as "HKF"), a subsidiary of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (hereinafter referred to as "NKF"), received the approval letter from the US Food and Drug Administration (FDA) for Eptifibatide injection.

2024-05-20

Learn more +
Enoxaparin Sodium Injection of NKF approved in Egypt

March 28, 2024, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (hereinafter referred to as "NKF) received the approval letter of Enoxaparin sodium injection fromEgyptian Drug Authority, the product officially launched in the market.

2024-05-14

Learn more +
Kindos’ (subsidiary of NKF) Bortezomib for injection getting approved by NMPA, submitted to NMPA and US FDA

April 30, 2024, Bortezomib for injection receives the approval letter by NMPA, formally approved for marketing in China, with independent research and development by Kindos Pharmaceuticals Co., Ltd (Hereinafter referred to ”Kindos”) .

2024-05-14

Learn more +
Good news! NKF and Livzon export Cetrorelix Acetate for Injection first time to US

On April 27, 2024, Nanjing King-Friend Biochemical Pharmaceutical Co.Ltd (hereinafter referred to as "NKF") and Livzon Group export Cetrorelix Acetate for Injection to the United States for the first time.

2024-04-29

Learn more +
Kindos creates the new record for fastest approval by FDA: Dacarbazine for Injection

On April 3, 2024, Dacarbazine for Injection of Kindos Pharmaceuticals Co., Ltd.（Subsidiary of Nanjing Kingfriend） got approved for commercial sale by US FDA via conditional accelerated approval.

2024-04-16

Learn more +
【Explore the future of the pharmaceutical industry】 Kingfriend will meet you in CPHI Barcelona!

2023-10-17

Learn more +

Stock price

13.320

-0.17

?2024 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd蘇ICP備13012010號

主站蜘蛛池模板： 99久久亚洲综合精品网站| 日韩国产精品一级毛片在线| 无码人妻一区二区三区免费n鬼沢| 日韩高清欧美| 蜜桃秘做爰免费网站| 免费啪视频在线观看视频日本| 精品无码人成视频手机| 国产精品自拍国产精品视频在| 丁香婷婷亚洲六月综合色| 91大神在线精品网址| 亚洲精品乱码久久久久久中文字幕 | 福利片免费一区二区三区| 91精品久久久久久| 无码动漫性爽xo视频在 | 男人的天堂AV亚洲一区2区| 精品久久香| 国产高清亚洲精品26u| 99久久精品费精品国产一区二| 亚洲av永久青草无码精品| 欧洲久久久精品| 精品亚洲成a人| 国产精品久久久久精品三级a| av人妻精品| 亚洲国产成人精品区| 欧美日韩亚洲一区二| 精品欧美亚洲日韩天堂一区二区三区在线 | 亚洲精品久久久一区| 欧美综合区自拍亚洲综合图| 果冻传媒91制品厂| 观看最新97日日碰人人模人人澡| 2024国产最新盗摄在线播放 | 狠狠色噜噜综合社区| 放荡的熟妇高清视频| 野外三级国产在线观看| 日本国产综合高清| 国产毛片一级片试看| av片免费大全在线观看不卡| 色婷婷小说| 久久久国产精品免费无码一区| 国产精品无码人妻99999| 99国产精品人妻无码免费|